Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Spain

 

Health care service write-offs drive losses at Bupa

Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?

NMC identifies $335m side deals and sacks CEO

In an announcement put out after trading, the independent review board appointed by NMC has identified side deals on procurement worth US$335m with the founders for which NMC is liable and that were made without board approval. It has also removed Mr Prasanth Manghat from his position of Director and CEO of the Company with immediate effect.

Fresenius shares jump 5% on 2019 results as Helios beats expectations

Listed dialysis, pharma and hospital group Fresenius has seen a 6% jump in its share price after 2019 results were better than some analysts expected. But with significant Asia exposure in certain businesses, CEO Stephan Sturm says: "Coronavirus is not going to be a positive for us."

KKR pulls out of Dentix deal

Global investment firm KKR has pulled out of a deal to take a majority stake in Spain’s biggest dental chain, Dentix, the company exclusively tells HBI. It is KKR's second high-profile decision not to invest in a large healthcare group this week.

How do you solve the Belgian bed problem?

Belgium's three regions have vastly different occupancy rates when it comes to nursing home beds. Would pan-European policy favouring the free movement of retirees be a way to lessen waiting lists by funnelling them toward markets more able to house them? We ponder the question with founder and managing director of Belgian real-estate advisory firm Anixton.

Icade eyeing Spanish investment

French property investor Icade Santé is looking to enter Spain this year, while growing its business in Germany and Italy. We discuss strategy with the company's head of healthcare.

Find Us